practolol has been researched along with Scleroderma, Systemic in 2 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Graham, JR | 1 |
McQueen, A | 1 |
Behan, WM | 1 |
2 other studies available for practolol and Scleroderma, Systemic
Article | Year |
---|---|
Drug-induced localized systemic scleroses.
Topics: Adrenergic beta-Antagonists; Humans; Methysergide; Metoprolol; Practolol; Propranolol; Scleroderma, | 1981 |
Immunofluorescence microscopy. The "string of Pearls" phenomenon-an immunofluorescent serological finding in patients screened for adverse drug reactions.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Dermatomyositis; Drug Eruptions; Epidermis; Esophagu | 1982 |